Biotech companies accelerate Nasdaq listings through reverse mergers
Life sciences start-ups are increasingly using reverse mergers to reach public markets faster, tapping a pool of struggling Nasdaq-listed biotech groups left behind by the pandemic-era IPO boom. ...